Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine...
-
Upload
rhoda-sherilyn-patrick -
Category
Documents
-
view
219 -
download
0
Transcript of Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine...
![Page 1: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/1.jpg)
Secondary Stroke Prevention
Dr Mehool Patel
Consultant Physician in Stroke & Elderly Medicine
Lewisham Healthcare NHS Trust
Lewisham, LONDON SE13 6LH
![Page 2: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/2.jpg)
Lewisham Healthcare NHS TrustLewisham LONDON SE13 6LH
![Page 3: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/3.jpg)
OBJECTIVES Risk Factors for stroke
Secondary Stroke Prevention:
- TIA assessment
- Anti-platelet therapy after stroke
- Hypertension after stroke
- Cholesterol after stroke
- Warfarin & newer kids on the block!
![Page 4: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/4.jpg)
STROKE 50 years ago !!!
HISTORY Stroke EXAMINATION Stroke
MANAGEMENT Prayers Will
![Page 5: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/5.jpg)
STROKE 17 years ago !!!
HISTORY Stroke EXAMINATION Stroke
MANAGEMENT Prayers Will
![Page 6: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/6.jpg)
Stroke care is a national priority!! 1999 National Clinical Guidelines for Stroke
National Sentinel Audit - RCP
2001 NSF for older people (5)
2005 National Audit Office report
2007 National Stroke StrategyMending hearts & brains - Roger Boyle
2008 HfL Stroke project
![Page 7: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/7.jpg)
Stroke is a medical emergency!
‘Brain attack’ ‘Time is brain’
Faster Assessment & Investigations
Acute medical treatment
Immediate secondary prevention
Recognition & management of complications
![Page 8: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/8.jpg)
Risk Factors Inherited
Behavioural
Physiological
![Page 9: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/9.jpg)
Risk Factors-InheritedFactor
Age 55-64 vs 75+
Male
Family history
Black
RR
5
1.3
2.3
2.2
![Page 10: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/10.jpg)
Stroke and age
Age specific rates per 1,000 population
0
5
10
15
20
25
<45 45-54 55-64 65-74 75-84 >84
Age group
rate
per
1,0
00
Erlangen 1.48London 1.14 P<0.001Dijon 0.93
![Page 11: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/11.jpg)
Stroke & Ethnicity
![Page 12: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/12.jpg)
Risk Factors- Behavioural
Factor
RR AR
Obesity 1.3
Physical inactivity 2.5
Hypercholesterolaemia 2.9
Acute Alcohol 5
Smoking 1.5 0.37
![Page 13: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/13.jpg)
Risk Factors - Pathological
Factor
RR AR
Hypertension 7 0.8
Cardiac disease 3 0.1
AF 3 – 7 0.24
TIA 5-13 0.15
Diabetes Mellitus M 4.1 0.18
F 5.8 0.22
Homocysteinaemia 1.3 – 2.8
![Page 14: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/14.jpg)
Stroke
Smoking
Excess alcoho
l
High blood
pressure
Diabetes
Family histor
y
High cholester
ol
Coronary artery
disease
Previous stroke/TIA (5-
13x)
Atrial fibrillatio
nAge
![Page 15: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/15.jpg)
Secondary Stroke Prevention
![Page 16: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/16.jpg)
Future risk can be predicted using lifestyle and clinical markers:
Any combination of these risk factors raises risk of further cardiovascular events considerably
Existing diseaseDiabetes
CKDStroke/TIA
PAD
Non-modifiable AgeGenderEthnicityFamily history
Modifiable Smoking
ObesityHypertension
LipidsGlycaemic control
Stress
Joint British Societies Guidelines on prevention of cardiovascular disease in clinical practice. Heart. 2005; 91 (Suppl V)
Managing the multivascular patient
![Page 17: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/17.jpg)
MANAGING RISK FACTORS
TIA
![Page 18: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/18.jpg)
Oxvasc Study
BMJ. 2004;328(7435):326.
![Page 19: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/19.jpg)
High risk TIA: ABCD2 ruleABCD risk stratification to identify stroke risk
Age > 601
Bpressure >140/90 1
Clinical weakness 2speech 1
Duration > 60 min 210-59 min 1
<10 min0
Diabetes1
![Page 20: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/20.jpg)
Risk stratification: ABCD2
Score % risk of stroke within 2 weeks
1 02 0
3 04 1
512% 6-7
31%
>3 admit Higher risk do present early after TIA Admit TIA on anticoagulants
![Page 21: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/21.jpg)
MANAGING RISK FACTORS
Anti-platelet agents
![Page 22: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/22.jpg)
Platelet Inhibition Pathways
ADP Pathway
TXA2 PathwayTXA2
TXA2 Receptor
ADP
ADP Receptor PLATELETPLATELET
Clopidogrel:Inhibits ADP platelet aggregation pathway
Clopidogrel:Inhibits ADP platelet aggregation pathway
CC
COXAspirin:
Inhibits thromboxaneA2 platelet
aggregation pathway
Aspirin:Inhibits thromboxane
A2 platelet aggregation pathway cAMP Pathway
PhosphodiesterasePhosphodiesterase
Dipyridamole: Inhibits
phosphodiesterase induced cAMP
release
Dipyridamole: Inhibits
phosphodiesterase induced cAMP
release
![Page 23: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/23.jpg)
Trials of all antiplatelet agents
*Vascular events = myocardial infarction, stroke or vascular death1. Antithrombotic Trialists’ Collaboration. BMJ 2002; 324: 71–86
Category % odds reduction
Acute myocardial infarction
Acute stroke
Prior myocardial infarction
Prior stroke/transient ischemic attack
CAD (e.g. unstable angina, heart failure)
PAD (e.g. intermittent claudication)
Risk of embolism (e.g. atrial fibrillation)
Other (e.g. diabetes)
All trials
1.00.50.0 1.5 2.0
Control betterAntiplatelet better
Aspirin (ASA) 75-150mg is effective in preventing cardiovascular events
![Page 24: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/24.jpg)
Mechanisms for Aspirin ‘failures’
Non-atheromatous causes: embolism / arteritis
Reduced bioavailability of aspirin: - non-compliance
- concurrent NSAID preventing access to CXO site
Alternative pathways of platelet activation: - AdP, epinephrine, thrombin receptors, collagen
stimulation - increased platelet sensitivity to collagen and AdP
turnover of platelets: bone marrow production in response to stress e.g. CABG and introducing new platelets
Genetic polymorphisms: platelet glycoprotein receptor (Ia/IIa, Ib/V/IX and IIb/IIIa), vWf receptor, CXO-I, CXO-2, tXA synthase
![Page 25: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/25.jpg)
CAPRIELancet 1996; 348: 1329–1339
19185 Stroke/MI/PVD MC,R: Aspirin (325) vs Clopidogrel (75) Composite: stroke/MI/vascular death 9.8% vs 10.7 % (RR 0.92, 95% CI: 0.85-1.00) Subgroup analyses: only PVD significant GI haemorrhages lower
![Page 26: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/26.jpg)
ESPS-2J Neurol Sci 1996;143:1-13
MC, R: 6602 TIA or stroke in preceding 3 mths
Aspirin (50) vs Dipyridamole (400) vs A+D vs placebo
3 primary outcomes: Stroke, death, stroke + death
Aspirin more effective than placebo (18.1% reduction in stroke)
No difference between aspirin vs Persantin alone Incidence of stroke in favour of A+D
9.5% vs 12.5% (RR 0.76; 0.63-0.93)
![Page 27: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/27.jpg)
ESPRITLancet 2006;367:1665-73
Aspirin vs Aspirin + Dipyridamole 2739 patients with TIA/Stroke Outcome: composite of first occurrence of:
- vascular deaths - non-fatal stroke
- non-fatal MI- major bleeding
complication
173 (13%) [A+D] vs 216 (16%) [A] (hazard ratio 0.80; ARR 1.0%/ year).
![Page 28: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/28.jpg)
Considerations of ESPRIT and ESPS2
ESPRIT1
For 50% of patients in the ESPRIT study aspirin dose was 50mg or below
Dropout rates in the combination arm were high at 34%, primarily due to adverse events particularly headache. The dropout rate in the aspirin only group was 13%
ESPS22 Aspirin dose in the ESPS2 study of dipyridamole and
aspirin in the secondary prevention of stroke does not reflect UK practice: a 25mg bd dose of ASA monotherapy was used, which is below recommended UK guidelines3,4
References:1. ESPRIT Study Group. Lancet 2006;367:1665–16732. Diener HC et al. European Stroke Prevention Study 2. J Neurol Sci 1996;143:1-133. Royal College Physicians. National clinical guidelines for stroke. 2nd edition, 20044. NICE TA 90. May 2005
![Page 29: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/29.jpg)
Sudlow, C. BMJ 2007;334:901
Meta-analysis of randomised trials of aspirin plus dipyridamole versus aspirin alone in patients with a prior ischaemic stroke or transient ischaemic attack (outcome: stroke, myocardial infarction, or vascular death) (adapted from the ESPRIT Study Group5)
![Page 30: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/30.jpg)
Review on A + DSudlow, C. BMJ 2007;334:901
Pooled analyses shows benefit post-stroke
Adding D to A prevents 1 death in 100 pts /yr
Discuss with patient regarding:- above advantage
- adverse effects esp headaches and GI effects - inconvenience of pills
![Page 31: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/31.jpg)
ANTITHROMBOTICS
Aspirin 300mg od for 2 weeks IST &
CAST
Followed by:
Clopidogrel 75 mg od Or
Aspirin 75 mg od + Dipyridamole Retard 200mg bd (for 2 years) ESPS2 + ESPRIT 2 (NICE recommendation)
Patients intolerant of Aspirin or ‘Aspirin’ failures: Clopidogrel 75mg od
![Page 32: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/32.jpg)
MANAGING RISK FACTORS
Hypertension after stroke
![Page 33: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/33.jpg)
British Museum: History of Medicine
![Page 34: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/34.jpg)
![Page 35: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/35.jpg)
Adapted from National Statistics Health Survey for England 2006; 1 (3): 1-25
0
10
20
30
40
50
60
70
16-24 25-34 35-44 45-54 55-64 65-74 >75
Age Group (Years)
Pre
va
len
ce
(%
) Men
Women
Prevalence of Hypertension (Health Survey of England, 2006)
Base: Aged 16 and over with three valid BP measurements
![Page 36: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/36.jpg)
Individuals aged 40-70 years, starting at BP 115/75 mmHg
Adapted from Lewington S et al. Lancet 2002; 360: 1903-1913
CVmortality
risk
SBP/DBP (mmHg)
0
1
2
3
4
5
6
7
8
115/75 135/85 155/95 175/105
1
2
4
8
Hypertension increases CV mortality risk
Doubles with each 20/10 mmHg BP increment
![Page 37: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/37.jpg)
RULE OF HALVES - 1
Only ½ of all hypertensives are aware of their condition
![Page 38: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/38.jpg)
RULE OF HALVES - 2
Of those aware of hypertension, only ½ are on treatment
![Page 39: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/39.jpg)
RULE OF HALVES - 3
Of those on treatment, only ½ are adequately controlled
![Page 40: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/40.jpg)
Hypertension & Stroke Common AR 0.8
IST 82%: SBP > 140CAST 75%
40% Already on Rx
Hypertension associated with poor outcome
No agreed consensus
![Page 41: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/41.jpg)
Hypertension after Acute Stroke : Reasons for no intervention
Natural history: reduction over 4-10 days
Dynamic cerebrovascular auto-regulation impaired
Consequences on ischaemic penumbral viability
Impaired Autonomic nervous system - impaired physiological response to systemic BP changes
Impairment of baroreceptor reflexAge & Ageing 2004;33:6-12
![Page 42: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/42.jpg)
Hypertension after Acute Stroke: Reasons for intervention
Sustained BP increases haemorrhagic transformation
IST: SBP>150 10mm:4.2% early recurrence
![Page 43: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/43.jpg)
Acute Stroke: Observational studies
Both high & low BP poor short-term prognosis
Others: No relationship
IST U-shaped relationship between BP & short-term mortality / long-term
outcomes 150
![Page 44: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/44.jpg)
Acute Rx: Interventional studies
ACE inhibitors: Captopril & perindropril: No effect PROGRESS (med 8 mths: interquartile 2-21 mths) HOPE ? 3 months; no clear definition of no.
B BlockersNo diff. at 6 mths with propranolol ? some effect with labetalol
Ca cha. block.47 trials! No benefitINWEST - nimodipine: deleterious
Nitrates clinical use not established
![Page 45: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/45.jpg)
Recent trials
CHHIPS : Control of Hypertension & Hypotension Immediately post-
stroke
ENOS:Efficacy of NO in Stroke
COSSACS:Continue Or Stop post-Stroke Antihypertensives Collaborative Study
![Page 46: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/46.jpg)
Managing Hypertension after stroke
Is there HOPE for PROGRESS after LIFE?
![Page 47: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/47.jpg)
HOPE- Heart Outcome Prevention Evaluation Study
9267 patients were randomised to Ramipril vs. placebo; >55 with one vascular disease or diabetes + one CV risk factor
32% stroke over 4 yrs
N Engl J Med. 2000 Jan 20;342(3):145-53.
![Page 48: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/48.jpg)
PROGRESS
Perindopril protection against recurrent stroke study
• Perindopril + indapamide
• 43% recurrent stroke
• 40% major vascular events
• No significant benefit of agent given alone
• Overall stroke risk reduction due to BP
Lancet. 2001 Sep 29;358(9287):1033-41
![Page 49: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/49.jpg)
LIFE
Losartan Intervention for Endpoint Reduction in hypertension study
• 9193 hypertensives with LVH
• Atenolol vs. Losartan : 4 years.
• No difference in BP
• 25% stroke risk with Losartan
How low is low enough? Which one do you use?Lancet 2002 Mar 23;359:995–1003
![Page 50: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/50.jpg)
Practical prescribing
![Page 51: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/51.jpg)
Hypertension after acute stroke
Anti-hypertensive therapy continued
New anti-hypertensive therapy after 10-14 days
Treat very high BP e.g. 220/120 urgently
![Page 52: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/52.jpg)
A B C D
![Page 53: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/53.jpg)
A C D
![Page 54: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/54.jpg)
MANAGING RISK FACTORS
Statins
![Page 55: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/55.jpg)
Cholesterol and Stroke
![Page 56: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/56.jpg)
LIPID Pathophysiology LIPIDS: cholesterol, triglycerides, cholesterol esters
Cholesterol uses: Steroids, Vitamin D, phospholipid layer: cell m.
LIPOPROTEINS: vascular lipids
Chylomicrons Lipoprotein lipase deficiencyVLDL Familial hypertriglyceridaemiaIDL HypobetalipoproteinemiaLDL Familial hypercholesterolemia
Combined hyperlipidemiaHDL
(good)
![Page 57: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/57.jpg)
Copyright ©2005 American College of Cardiology Foundation. Restrictions may apply.
Ray, K. K. et al. J Am Coll Cardiol 2005;46:1425-1433
LIPIDS & STATINS: Molecular pathway
![Page 58: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/58.jpg)
Statins: CVD prevention Ameliorate endothelial dysfunction
Suppress inflammatory response shown by reduction of inflammatory cells in atherosclerotic plaque
Stabilise plaques; inhibit cholesterol accumulation on macrophages & inhibit smooth muscle cell proliferation
Reduce platelet aggregation and thereby reduce thrombus formation
Limit recurrent MI, thereby prevent LV dysfunction, minimising cardioembolic stroke.
![Page 59: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/59.jpg)
![Page 60: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/60.jpg)
Statins after Stroke - SSSS
- WOSCOPS- CARE- LIPID
Chol >5.0 and IHD
- MRC BHP studyNormal cholesterol
![Page 61: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/61.jpg)
Statins & Stroke Heart Protection Study
DBPC RCT: 20, 536 CHD/Stroke/PVD ‘Strokes without CHD’
Statins + anti-oxidant vitamins
3286 Strokes CHD (1820 without CHD) 25 % reduction in ischaemic strokes
No difference in haemorrhagic strokes
Simvastatin prevents vascular events independent of pretreatment cholesterol, TG, age, sex, smoking or treatment of hypertension
![Page 62: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/62.jpg)
CAUTION - STATINS Caution in our clinical practice?
• Side effects of Statins
• Costs
• High risk patients vs population Rx
• J shaped relationship with stroke• Relative risk reduction
![Page 63: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/63.jpg)
STATIN ‘failures’
RR with Statins about 30%
50% of CVD pts have normal cholesterol - LDL C
HDL would thus have a role in CVD prevention
![Page 64: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/64.jpg)
MANAGING RISK FACTORS
Warfarin in Atrial Fibrillation
![Page 65: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/65.jpg)
Implications of AF in stroke
Incidence of stroke attributed to AF:• 1.5% at 50-59 yrs• 23.5% at 80-89 yrs
Stroke patients AF associated with:• Increased length of inpatient stay• Lower rate of discharge home
![Page 66: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/66.jpg)
![Page 67: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/67.jpg)
CHADS 2 score Congestive cardiac failure (any Hx) 1 Hypertension (prior Hx) 1 Age > 75 1 Diabetes mellitus 1 Secondary prevention: previous stroke/ TIA
(or systemic emboli) 2
• Low risk = 0
• Intermediate risk = 1-2
• High risk = 3 or more
BALANCE RISK vs BENEFIT
![Page 68: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/68.jpg)
Warfarin after Stroke No overall benefit in acute stroke (heparin)
- Increase risk of haemorrhagic transformation!
Consider WARFARIN if AF after two weeks:confusion
falls bleeding
conditions practical feasibility
Discussion / Documentation of risk/benefit
![Page 69: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/69.jpg)
Newer anticoagulants on the block!
Warfarin: - narrow therapeutic index
- variable pharmacodynamics & pharmacokinetics - dose monitoring
- drug and food interactions (lifestyle implications)
Dabigatran (licensed) 150 / 100 mg bd
Apixaban and Rivaroxaban
![Page 70: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/70.jpg)
Investigations – secondary prevention
Blood testsFBC, ESR
U&E, Blood glucose, LFT, Lipid profile? Clotting screen & Thrombophilia screen
? Autoantibodies: anticardiolipin? Lupus anticoagulant & Sickle cell
? Homocysteine
ECG and ? CXR Brain imaging (CT or MRI + MRA) Carotid artery imaging (U/S or Angiography)
Echocardiography (TTE / ?TOE) 24 hour tape
![Page 71: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/71.jpg)
What have you learnt? Risk Factors for stroke
Early TIA assessment
Anti-platelet therapy after Stroke
Hypertension after stroke
Cholesterol after stroke
Warfarin and new kids on the block!
![Page 72: Secondary Stroke Prevention Dr Mehool Patel Consultant Physician in Stroke & Elderly Medicine Lewisham Healthcare NHS Trust Lewisham, LONDON SE13 6LH mehool.patel@nhs.net.](https://reader036.fdocuments.in/reader036/viewer/2022062321/56649e305503460f94b20c96/html5/thumbnails/72.jpg)
“it is the duty of the physician to explain to the patient, or to his friends, that the condition is past relief, that medicines and electricity will do no good, and that there is no possible hope of cure”
William Osler